Immune Thrombocytopenia That Developed After Use of Isoniazide (INH) for Tuberculosis Prophylaxis: A Case Report
Osman Yiğitoğlu1
, Umut Yorulmaz1, Mustafa Gençeli3, Özge Metin Akcan3, Hüseyin Tokgöz2, Sevgi Pekcan4
1Necmettin Erbakan University Medical School, Pediatrics, Konya, Türkiye
2Necmettin Erbakan University Medical School, Pediatric Hematology, Konya, Türkiye
3Necmettin Erbakan University Medical School, Pediatric Infectious Disease, Konya, Türkiye
4Necmettin Erbakan University Medical School, Pediatric Pulmonology, Konya, Türkiye
Keywords: Thrombocytopenia, immune, isoniazid, tuberculosis
Abstract
Tuberculosis has is an important public health issue that has been leading to morbidity and mortality for ages. A treatment for the disease is available; but the most significant problem is adherence to treatment. The leading reason for poor adherence to treatment is side effects of the drugs. We present an 8-year-old male boy with immune thrombocytopenia, a rare complication on isoniazid prophylaxis for tuberculosis, to contribute to the literature. Questioning for drug use is important in cases diagnosed with immune thrombocytopenia.
Cite this article as: Yiğitoğlu O, Yorulmaz U, Gençeli M, Metin Akcan Ö, Tokgöz H, Pekcan S. Immune thrombocytopenia that developed after use of isoniazide (INH) for tuberculosis prophylaxis: a case report. Pediatr Acad Case Rep. 2026;5(3):60-3.
The parents’ of this patient consent was obtained for this study.
Concept: OY,UY; design: OY,UY; supervision: SP; materials: MG,ÖMA; data collection and/or processing: OY,HT; analysis and interpretation: HT; literature review: OY,UY; writing manuscript: OY; critical reviews: SP. All authors contributed to the final version of the manuscript and discussed the results and contributed to the final manuscript.
The authors declared no conflicts of interest with respect to authorship and/or publication of the article.
The authors received no financial support for the research and/or publication of this article.